Hot and Cold Compress in Hemodialysis
Study Details
Study Description
Brief Summary
Aims and objectives. To examine and compare the effects of hot and cold compresses administration on muscle cramps, fatigue, and comfort in hemodialysis (HD) patients.
Background. Muscle cramps and fatigue are common complications in HD patients and reduce patient comfort. Among the nursing interventions stated for the management of these complications in the literature, hot and cold therapy are remarkable. To the best of our knowledge, the present study is the first research up to date that examined and compared the effects of hot and cold compress administrations on abovementioned complications in HD.
Design. This placebo-controlled randomized trial was conducted in two hemodialysis centers between February and October 2020.
Methods. The study sample consisted of 69 patients, stratified and randomly allocated to two intervention groups and placebo group. For patients of each group, the implementation of the study continued for four weeks, 12 HD sessions.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Hemodialysis (HD) is a common renal replacement therapy used in the treatment of End-Stage Renal Disease (ESRD) worldwide. Although HD is a life-saving treatment for people with ESRD, it causes some acute and chronic complications. Muscle cramps and fatigue are two of the most common complications in HD, and these also cause reducing comfort. Management of complications in HD patients and ensuring an optimal comfort level are pivotal for nurses. According to the literature, recommended nursing practices for the management of cramps in HD patients include hot and cold therapy methods. Besides, preventing cramps can improve comfort by reducing fatigue. Therefore, this study aimed to examine and compare the effects of hot and cold compresses administration on muscle cramps, fatigue, and comfort in hemodialysis (HD) patients.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: HOT THERAPY:GROUP A Hot Compress Group |
Other: Hot and Cold compress, nursing interventions
using thermal compress at 38-39 °C (hot) and 15-16 °C (cold) on the distal regions of both lower extremities of the patients
|
Experimental: COLD THERAPY:GROUP B Cold Compress Group |
Other: Hot and Cold compress, nursing interventions
using thermal compress at 38-39 °C (hot) and 15-16 °C (cold) on the distal regions of both lower extremities of the patients
|
Placebo Comparator: PLACEBO: GROUP C Inoperative compress Group |
Other: Hot and Cold compress, nursing interventions
using thermal compress at 38-39 °C (hot) and 15-16 °C (cold) on the distal regions of both lower extremities of the patients
|
Outcome Measures
Primary Outcome Measures
- muscle cramps [4 weeks]
Throughout the hemodialysis treatment, the patients were monitored in terms of cramp development and cramp development was recorded in the follow-up chart (CEFC). This chart was created by the researcher through literature review. Each involuntary contraction session in the legs of the patients was evaluated as an episode.
Secondary Outcome Measures
- Fatigue [4 weeks]
At the end of each hemodialysis session, the fatigue level of all participants was measured and recorded using the Piper Fatigue Scale.
Other Outcome Measures
- Comfort [4 weeks]
At the end of each hemodialysis session, the comfort level of all participants was measured and recorded using the Hemodialysis Comfort Scale
Eligibility Criteria
Criteria
Inclusion Criteria:
-
between the ages of 18-65,
-
receiving HD treatment for at least six months,
-
three days a week with four-hour sessions
-
with blood pressure 120/80 mmHg and higher at the beginning of the HD session,
-
did not develop intradialytic hypotension in the first two hours of HD,
-
hemoglobin value above 8.0 mg/dL,
-
having a stable dry weight for the previous month (less than 2 kg change).
Exclusion Criteria:
-
receiving intravenous electrolyte replacement during HD session,
-
having a condition that prevented hot or cold administration such as diabetic neuropathy, burns, open wounds, and amputation in the lower extremities,
-
with an oncological diagnosis or autoimmune disease (rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, fibromyalgia, etc.),
-
refused to participate in the study
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Hacettepe University | Ankara | None Selected | Turkey | 06100 |
Sponsors and Collaborators
- Hacettepe University
Investigators
- Study Director: Leyla Özdemir, Prof. Dr., Hacettepe University
- Study Director: Tolga Yıldırım, Assos. Prof., Hacettepe University
- Study Chair: Cebrail Cebrailov, M.D., Hacettepe University
- Study Chair: Gülseren Çeliksöz, M.D., Betamar Dialysis Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- KA-19143